- 20+ sessions exclusively for rare disease commercialization, from go-to-market blueprints to patient-first planning
- 16+ powerhouse speakers steering some of the most innovative rare disease launches today, like Takeda, Sobi, Amgen, BioMarin and more
- Get ahead with Data, Diagnostics & Market Access with our breakthrough sessions in patient identification, diagnosis evolution and more
- Engage and connect directly with senior executives, commercialization experts and rare disease specialists
- Integrate patient’s voice into every stage of your strategy and learn how leading companies redefine access, and make real impact in rare disease communities.
